Director Childs Buys 29,000 BHVN Shares

Today’s most notable transaction comes from John W. Childs, director of Biohaven Pharmaceutical Holding Company $BHVN.

Childs bought 29,000 shares, equivalent to $1,042,393 in its latest Form 4 filing.

Here’s The Hot Corner, with data from December 31, 2024:

Happy New Year, everyone!